| 1 |
Zhou Y, Zhao B, Shi W, Ding X, Shen L, Zhou X, He H. The infection rates of HBV and HCV decreased significantly in Zhejiang Province, China: A comparative study based on the data of two sero-epidemiological surveys in 1992 and 2020. J Viral Hepat 2023. [PMID: 36807422 DOI: 10.1111/jvh.13820] [Reference Citation Analysis]
|
| 2 |
Marjenberg Z, Wright C, Pooley N, Cheung KW, Shimakawa Y, Vargas-Zambrano JC, Vidor E. HBsAg prevalence and the rates of mother-to-child transmission of hepatitis B virus following the introduction of infant vaccination programmes in South East Asia and Western Pacific regions: a systematic review. Int J Infect Dis 2022:S1201-9712(22)00503-3. [PMID: 36089151 DOI: 10.1016/j.ijid.2022.09.003] [Reference Citation Analysis]
|
| 3 |
Jiang M, Zhu B, Yao Q, Lou H, Zhang X. Anti-HBs levels in children under the age of two years born to HBV carrier mothers after immunoprophylaxis: a multicenter cross-sectional study. BMC Pediatr 2021;21:492. [PMID: 34736435 DOI: 10.1186/s12887-021-02967-8] [Reference Citation Analysis]
|
| 4 |
Sun X, Zhu Y, Tang F, Deng X, Wang Z, Liu Y. Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China. Hum Vaccin Immunother 2021;17:3729-34. [PMID: 34096830 DOI: 10.1080/21645515.2021.1928461] [Reference Citation Analysis]
|
| 5 |
Zhou Y, Lu Z, He H, Yan R, Deng X, Tang X, Zhu Y, Xu X. Influencing factors and necessity of post-vaccination serologic testing follow-up for HBsAg-positive mothers and their infants: A 5-year prospective study in Zhejiang Province, China (2016-2020). J Viral Hepat 2021;28:1413-21. [PMID: 34310810 DOI: 10.1111/jvh.13581] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 6 |
Lebossé F, Zoulim F. [Hepatitis B vaccine and liver cancer]. Bull Cancer 2021;108:90-101. [PMID: 33358507 DOI: 10.1016/j.bulcan.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Liu Y, Ren J, Wu Z, Shen L, Shan H, Dai X, Li J, Qiu Y, Ren W, Yao J, Li L. The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China. Hum Vaccin Immunother 2021;17:1530-5. [PMID: 33315518 DOI: 10.1080/21645515.2020.1814096] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Cabezas C, Trujillo O, Balbuena J, Peceros FM, Terrazas M, Suárez M, Marin L, Apac J, Ramírez-Soto MC. Decrease in the prevalence of hepatitis B and D virus infections in an endemic area in Peru 23 years after the introduction of the first pilot vaccination program against hepatitis B. PLoS One 2020;15:e0236993. [PMID: 32760100 DOI: 10.1371/journal.pone.0236993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 9 |
Zeng Y, Luo M, Lin J, He H, Deng X, Xie S, Fang Y. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobulin treatment: a case study in Zhejiang Province, East China. Hum Vaccin Immunother 2020;16:955-64. [PMID: 31769718 DOI: 10.1080/21645515.2019.1688031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Zhao H, Zhou YH. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no? Hum Vaccin Immunother 2018;14:456-63. [PMID: 29083945 DOI: 10.1080/21645515.2017.1397243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
